Smoking cessation explained

Smoking cessation, usually called quitting smoking or stopping smoking, is the process of discontinuing tobacco smoking.[1] Tobacco smoke contains nicotine, which is addictive and can cause dependence.[2] As a result, nicotine withdrawal often makes the process of quitting difficult.

Smoking is the leading cause of preventable death and a global public health concern.[3] Tobacco use leads most commonly to diseases affecting the heart and lungs, with smoking being a major risk factor for heart attacks,[4] [5] strokes,[6] chronic obstructive pulmonary disease (COPD),[7] idiopathic pulmonary fibrosis (IPF),[8] emphysema,[7] and various types and subtypes of cancers[9] (particularly lung cancer, cancers of the oropharynx,[10] larynx,[10] and mouth,[10] esophageal and pancreatic cancer).[11] Smoking cessation significantly reduces the risk of dying from smoking-related diseases.[12] [13] The risk of heart attack in a smoker decreases by 50% after one year of cessation. Similarly, the risk of lung cancer decreases by 50% in 10 years of cessation [14]

From 2001 to 2010, about 70% of smokers in the United States expressed a desire to quit smoking, and 50% reported having attempted to do so in the past year. Many strategies can be used for smoking cessation, including abruptly quitting without assistance ("cold turkey"), cutting down then quitting, behavioral counseling, and medications such as bupropion, cytisine, nicotine replacement therapy, or varenicline. In recent years, especially in Canada and the United Kingdom, many smokers have switched to using electronic cigarettes to quit smoking tobacco.[15] [16] [17] However, a 2022 study found that 20% of smokers who tried to use e-cigarettes to quit smoking succeeded but 66% of them ended as dual users of cigarettes and vape products one year out.[18]

Most smokers who try to quit do so without assistance. However, only 3–6% of quit attempts without assistance are successful long-term.[19] Behavioral counseling and medications each increase the rate of successfully quitting smoking, and a combination of behavioral counseling with a medication such as bupropion is more effective than either intervention alone.[20] A meta-analysis from 2018, conducted on 61 randomized controlled trials, showed that among people who quit smoking with a cessation medication (and some behavioral help), approximately 20% were still nonsmokers a year later, as compared to 12% who did not take medication.[21]

In nicotine-dependent smokers, quitting smoking can lead to nicotine withdrawal symptoms such as nicotine cravings, anxiety, irritability, depression, and weight gain.[22] Professional smoking cessation support methods generally attempt to address nicotine withdrawal symptoms to help the person break free of nicotine addiction.

Smoking cessation methods

Unassisted

It often takes several attempts, and potentially utilizing different approaches each time, before achieving long-term abstinence. Over 74.7% of smokers attempt to quit without any assistance,[23] otherwise known as "cold turkey", or with home remedies. Previous smokers make between an estimated 6 to 30 attempts before successfully quitting.[24] Identifying which approach or technique is eventually most successful is difficult. It has been estimated, for example, that only about 4% to 7% of people are able to quit smoking on any given attempt without medicines or other help.[2] [25] The majority of quit attempts are still unassisted, though the trend seems to be shifting. In the U.S., for example, the rate of unassisted quitting fell from 91.8% in 1986 to 52.1% during 2006 to 2009.[26] The most frequent unassisted methods were "cold turkey",[26] a term that has been used to mean either unassisted quitting or abrupt quitting and "gradually decreased number" of cigarettes, or "cigarette reduction".[27]

Cold turkey

"Cold turkey" is a colloquial term indicating abrupt withdrawal from an addictive drug. In this context, it indicates sudden and complete cessation of all nicotine use. In three studies, it was the quitting method cited by 76%,[28] 85%,[29] or 88%[30] of long-term successful quitters. In a large British study of ex-smokers in the 1980s, before the advent of pharmacotherapy, 53% of the ex-smokers said that it was "not at all difficult" to stop, 27% said it was "fairly difficult", and the remaining 20% found it very difficult.[31] Studies have found that two-thirds of recent quitters reported using the cold turkey method and found it helpful.[32]

Cutting down to quit

Gradual reduction involves slowly reducing one's daily intake of nicotine. This method can theoretically be accomplished through repeated changes to cigarettes with lower nicotine levels, by gradually reducing the number of cigarettes smoked daily, or by smoking only a fraction of a cigarette on each occasion. A 2009 systematic review by researchers at the University of Birmingham found that gradual nicotine replacement therapy could be effective in smoking cessation. There is no significant difference in quit rates between smokers who quit by gradual reduction or abrupt cessation as measured by abstinence from smoking of at least six months from the quit day. The same review also looked at five pharmacological aids for reduction. When reducing the number of smoked cigarettes, it found some evidence that additional varenicline or fast-acting nicotine replacement therapy can positively affect quitting for six months or longer.[33]

Medications

The American Cancer Society notes that "Studies in medical journals have reported that about 25% of smokers who use medicines can stay smoke-free for over 6 months."[34] Single medications include:

The 2008 US Guideline specifies that three combinations of medications are effective:[46]

A meta-analysis from 2018, conducted on 61 RCTs, showed that during their first year of trying to quit, approximately 80% of the participants in the studies who got drug assistance (bupropion, NRT, or varenicline) returned to smoking, while 20% continued to not smoke for the entire year (i.e.: remained sustained abstinent).[21] In comparison, 12% the people who got placebo kept from smoking for (at least) an entire year.[21] This makes the net benefit of the drug treatment to be 8% after the first 12 months.[21] In other words, out of 100 people who will take medication, approximately 8 of them would remain non-smoking after one year thanks to the treatment.[21] During one year, the benefit from using smoking cessation medications (Bupropion, NRT, or varenicline) decreases from 17% in 3 months, to 12% in 6 months to 8% in 12 months.[21]

Community interventions

Community interventions using "multiple channels to provide reinforcement, support and norms for not smoking" may have an effect on smoking cessation outcomes among adults.[50] Specific methods used in the community to encourage smoking cessation among adults include:

Pharmacist Interventions

Pharmacist-led interventions have proven to be effective in helping smoking cessation attempts. Many systematic reviews have looked at the importance of pharmacist involvement. In Malaysia, their study looked at how pharmacist intervention in patients' overall healthcare showed improvements in screening early stages of disease.[58] This allowed for earlier treatment starts in smoking-caused COPD. In addition, pharmacists in Malaysia could prescribe NRT products, and when they led a smoking cessation service, it was more successful than other smoking cessation trials in Malaysia.[58] It was also shown that pharmacist counselling and NRT products were more effective in smoking cessation than using NRT alone.

In pharmacist-led smoking cessation services in Ethiopia, the study found statistically and clinically significant benefits favouring pharmacist intervention.[59] They found that structured care, and regular visits, easy accessibility to pharmacists helped more people trying to quit than without. However, the study concluded that more research should be done in the area as they found an unknown risk of bias in the studies included[59]

Another systematic review analyzed pharmacist intervention in smoking cessation and alcohol and weight interventions.[60] They found that evidence suggests that the longer the duration of pharmacist-led intervention, the more influential the attempt at quitting was[60] In addition, they found that community pharmacists were beneficial in delivering public health information. Pharmacists have a great reach in the community to help with smoking cessation and have proven to help with lifestyle modifications and proper NRT use.[60]

Digital interventions

Psychosocial approaches

How to set a quit date

Most smoking cessation resources such as the Centers for Disease Control and Prevention (CDC)[90] and The Mayo Clinic[91] encourage smokers to create a quit plan, including setting a quit date, which helps them anticipate and plan for smoking challenges. A quit plan can improve a smoker's chance of a successful quit[92] [93] [94] as can setting Monday, as the quit date, given that research has shown that Monday more than any other day is when smokers are seeking information online to quit smoking[95] and calling state quitlines.[96] In Nepal, smokers are not selfish, a health campaign of two weeks is started on the occasion of Valentine day and Vasant panchami to motiviate individuals to quit smoking as a sacrifice for their loved ones and making it a meaningful decision of life. This campaign is taking public attention. [97]

Self-help

Self-help materials may produce a small increase in quit rates specially when there is no other supporting intervention form.[98] "The effect of self-help was weak", and the number of types of self-help did not produce higher abstinence rates.[46] Nevertheless, self-help modalities for smoking cessation include:

In one survey of adult smokers, 88% reported a history of spiritual practice or belief, and of those more than three-quarters were of the opinion that using spiritual resources may help them quit smoking.[104]

Biochemical feedback

Various methods allow a smoker to see the impact of their tobacco use and the immediate effects of quitting. Using biochemical feedback methods can allow tobacco users to be identified and assessed, and monitoring throughout an effort to quit can increase motivation to quit.[107] [108] Evidence-wise, little is known about the effects of using biomechanical tests to determine a person's risk related to smoking cessation.[109]

While both measures offer high sensitivity and specificity, they differ in usage method and cost. For example, breath CO monitoring is non-invasive, while cotinine testing relies on bodily fluid. For instance, these two methods can be used alone or together when abstinence verification needs additional confirmation.[112]

Competitions and incentives

Financial or material incentives to entice people to quit smoking improve smoking cessation while the motivation is in place.[113] Competitions that require participants to deposit their own money, "betting" that they will succeed in quitting smoking, appear to be an effective incentive. However, it is more difficult to recruit participants for this type of contest in head-to-head comparisons with other incentive models, such as giving participants NRT or placing them in a more typical rewards program.[114] Evidence shows that incentive programs may be effective for pregnant mothers who smoke. As of 2019, there is an insufficient number of studies on "quit and win," and other competition-based interventions and results from the existing studies were inconclusive.[115]

Workplace incentives

A 2008 Cochrane review of smoking cessation activities in work-places concluded that "interventions directed towards individual smokers increase the likelihood of quitting smoking".[116] A 2010 systematic review determined that worksite incentives and competitions needed to be combined with additional interventions to produce significant increases in smoking cessation rates.[117]

Healthcare systems

Interventions delivered via healthcare providers and healthcare systems have been shown to improve smoking cessation among people who visit those services.

Substitutes for cigarettes

See main article: Nicotine replacement therapy.

There is high‐certainty evidence that ECs with nicotine increase quit rates compared to NRT and moderate‐certainty evidence that they increase quit rates compared to ECs without nicotine.[129] Little is known regarding the long-term harms related to vaping.[130] A 2016 UK Royal College of Physicians report supports using e-cigarettes as a smoking cessation tool.[131] A 2015 Public Health England report stated that "Smokers who have tried other methods of quitting without success could be encouraged to try e-cigarettes (EC) to stop smoking and stop smoking services should support smokers using EC to quit by offering them behavioural support."[132] However, since little is known about long term effects, other regulated options such as nicotine replacement therapy, varenicline or bupropion should be discussed primarily.

Alternative approaches

It is important to note that most of the alternative approaches below have minimal evidence to support their use, and their efficacy and safety should be discussed with a healthcare professional before starting.

Acupuncture has been explored as an adjunct treatment method for smoking cessation.[133] A 2014 Cochrane review was unable to make conclusions regarding acupuncture as the evidence is poor.[134] A 2008 guideline found no difference between acupuncture and placebo, found no scientific studies supporting laser therapy based on acupuncture principles but without the needles.

Hypnosis often involves the hypnotherapist suggesting the unpleasant outcomes of smoking to the patient.[135] Clinical trials studying hypnosis and hypnotherapy as a method for smoking cessation have been inconclusive.[136] [137] A Cochrane review was unable to find evidence of benefit of hypnosis in smoking cessation, and suggested if there is a beneficial effect, it is small at best.[138] However, a randomized trial published in 2008 found that hypnosis and nicotine patches "compares favorably" with standard behavioral counseling and nicotine patches in 12-month quit rates.[139]

Many herbs have been studied as a method for smoking cessation, including lobelia and St John's wort.[140] [141] The results are inconclusive, but St. Johns Wort shows few adverse events, but is a contraindication to many medications. Lobelia has been used to treat respiratory diseases like asthma and bronchitis, and has been used for smoking cessation because of chemical similarities to tobacco; lobelia is now listed in the FDA's Poisonous Plant Database.[142] Lobelia can still be found in many products sold for smoking cessation and should be used with caution. Herbal products should be discussed with healthcare professionals before use to confirm safety with other medications.

There is little smoking in Sweden, which is reflected in the very low cancer rates for Swedish men. Use of snus (a form of steam-pasteurized, rather than heat-pasteurized, air-cured smokeless tobacco) is an observed cessation method for Swedish men and even recommended by some Swedish doctors.[143] However, the report by the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) concludes "STP (smokeless tobacco products) are addictive and their use is hazardous to health. Evidence on the effectiveness of STP as a smoking cessation aid is insufficient."[144] A recent national study on the use of alternative tobacco products, including snus, did not show that these products promote cessation.[145]

It is a method of treatment works by pairing the pleasurable stimulus of smoking with other unpleasant stimuli. A Cochrane review reported that there is insufficient evidence of its efficacy.[146]

Nicotine vaccines (e.g., NicVAX and TA-NIC) work by reducing the amount of nicotine reaching the brain; however, this method of therapy needs more investigations to establish its role and determine its side effects.[147]

Special populations

Children and adolescents

Methods used with children and adolescents include:

Cochrane reviews, mainly of studies combining motivational enhancement and psychological support, concluded that "complex approaches" for smoking cessation among young people show promise.[152] [156] The 2008 US Guideline recommends counselling-style support for adolescent smokers on the basis of a meta-analysis of seven studies.[46] Neither the Cochrane review nor the 2008 Guideline recommend medications for adolescents who smoke.

Pregnant women

Smoking during pregnancy can cause adverse health effects in both the woman and the fetus. The 2008 US Guideline determined that "person-to-person psychosocial interventions" (typically including "intensive counseling") increased abstinence rates in pregnant women who smoke to 13.3%, compared with 7.6% in usual care.[46] Mothers who smoke during pregnancy have a greater tendency towards premature births. Their babies are often underdeveloped, have smaller organs, and weigh much less than the average baby weight. In addition, these babies have weaker immune systems, making them more susceptible to many diseases such as middle ear inflammations and asthmatic bronchitis, as well as metabolic conditions such as diabetes and hypertension, all of which can bring significant morbidity.[157] Additionally, a study published by American Academy of Pediatrics shows that smoking during pregnancy increases the chance of sudden unexpected infant death ((SUID) or (SIDS)).[158] There is also an increased chance that the child will be a smoker in adulthood. A systematic review showed that psychosocial interventions help women quit smoking in late pregnancy and can reduce the incidence of low birth weight infants.[159]

It is a myth that a female smoker can cause harm to a fetus by quitting immediately upon discovering she is pregnant. This idea is not based on any medical study or fact.[160]

In a UK study that included 1140 pregnant women, e-cigarettes were found to be as effective as nicotine patches at helping pregnant women to quit smoking. The safety of the two products was also similar.[161] [162] However, life style modification are the preferred method for pregnant women, and they should discuss smoking cessation techniques with a healthcare professional.

Schizophrenia

See main article: Schizophrenia and tobacco smoking. Studies across 20 countries show a strong association between patients with schizophrenia and smoking. People with schizophrenia are much more likely to smoke than those without the disease.[163] For example, in the United States, 80% or more of people with schizophrenia smoke, compared to 20% of the general population in 2006.[164]

Hospitalized smokers

Smokers who are hospitalised may be particularly motivated to quit.[46] A 2012 Cochrane review found that interventions beginning during a hospital stay and continuing for one month or more after discharge were effective in producing abstinence.[165]

Patients undergoing elective surgery may get benefits of preoperative smoking cessation interventions, when starting 4–8 weeks before surgery with weekly counseling for behavioral support and use of nicotine replacement therapy.[166] It is found to reduce the complications and the number of postoperative morbidity.[166]

Mood disorders

People with mood disorders or attention deficit hyperactivity disorders have a greater chance to begin smoking and a lower chance of quitting smoking. A higher correlation with smoking has also been seen in people diagnosed with the major depressive disorder at any time throughout their lifetime compared to those without it. Success rates in quitting smoking were lower for those with a major depressive disorder diagnosis versus people without the diagnosis. Exposure to cigarette smoke early on in life, during pregnancy, infancy, or adolescence, may negatively impact a child's neurodevelopment and increase the risk of developing anxiety disorders in the future.[167]

Homeless and poverty

Homelessness doubles the likelihood of an individual currently being a smoker. Homelessness is independent of other socioeconomic factors and behavioral health conditions. Homeless individuals have the same rates of desire to quit smoking. Still, they are less likely than the general population to attempt to stop successfully.[168] [169]

In the United States, 60–80% of homeless adults are smokers. This is a considerably higher rate than the general adult population of 19%.[168] Many current smokers who are homeless report smoking as a means of coping with "all the pressure of being homeless."[168] The perception that homeless people smoking being "socially acceptable" can reinforce these trends.[168]

Americans under the poverty line have higher rates of smoking and lower rates of quitting than those over the poverty line.[169] [170] [171] While the homeless population is concerned about short-term effects of smoking, such as shortness of breath or recurrent bronchitis, they are not as concerned with long-term consequences.[170] The homeless population has unique barriers to quitting smoking, such as unstructured days, the stress of finding a job, and immediate survival needs that supersede the desire to quit smoking.[170]

These unique barriers can be combated through pharmacotherapy and behavioral counseling for high levels of nicotine dependence. The emphasis of immediate financial benefits to those who concern themselves with the short-term over the long-term, partnering with shelters to reduce the social acceptability of smoking in this population, and increased taxes on cigarettes and alternative tobacco products to further make the addiction more difficult to fund.[172]

Concurrent substance use disorders

Over three-quarters of people in treatment or recovery from substance misuse issues are current smokers.[173] [174] Providing behavioural interventions (such as counseling and advice) and pharmacotherapy including nicotine replacement therapy (such as the use of patches or gum, varenicline, and/or bupropion) increase tobacco abstinence that is sustainable and also reduces the risk of returning to other substance use.[175] [176] [177]

Comparison of success rates

Comparison of success rates across interventions can be difficult because of different definitions of "success" across studies.[165] Robert West and Saul Shiffman, authorities in this field recognized by government health departments in a number of countries, have concluded that, used together, "behavioral support" and "medication" can quadruple the chances that a quit attempt will be successful.

A 2008 systematic review in the European Journal of Cancer Prevention found that group behavioural therapy was the most effective intervention strategy for smoking cessation, followed by bupropion, intensive physician advice, nicotine replacement therapy, individual counselling, telephone counselling, nursing interventions, and tailored self-help interventions; the study did not discuss varenicline.[178]

Factors affecting success

Quitting can be harder for individuals with darkly pigmented skin than individuals with pale skin since nicotine has an affinity for melanin-containing tissues. Studies suggest this can cause the phenomenon of increased nicotine dependence and lower smoking cessation rate in darker-pigmented individuals.[179]

There is an important social component to smoking. The spread of smoking cessation from person to person contributes to the decrease in smoking among different populations or groups.[180] A 2008 study of a densely interconnected network of over 12,000 individuals found that smoking cessation by any given individual reduced the chances of others around them lighting up by the following amounts: a spouse by 67%, a sibling by 25%, a friend by 36%, and a coworker by 34%. Nevertheless, a Cochrane review determined that interventions to increase social support for a smoker's cessation attempt did not improve long-term quit rates.[181]

Smokers trying to quit are faced with social influences that may persuade them to conform and continue smoking. Cravings are easier to detain when one's environment does not provoke the habit. Suppose a person who stopped smoking has close relationships with active smokers. In that case, they are often put into situations that make the urge to conform more tempting. However, in a small group with at least one other not smoking, the likelihood of conformity decreases. The social influence of smoking cigarettes has been proven to rely on simple variables. One researched variable depends on whether there is influence from a friend or non-friend. The research shows that individuals are 77% more likely to conform to non-friends, while close friendships decrease conformity. Therefore, if an acquaintance offers a cigarette as a polite gesture, the person who has stopped smoking will be likelier to break his commitment than if a friend had suggested it. Recent research from the International Tobacco Control (ITC) Four Country Survey of over 6,000 smokers found that smokers with fewer smoking friends were more likely to intend to quit and to succeed in their quit attempt.[182]

Expectations and attitude are significant factors. A self-perpetuating cycle occurs when a person feels bad for smoking yet smokes to alleviate feeling bad. Breaking that cycle can be a key in changing the sabotaging attitude.[183]

Smokers with major depressive disorder may be less successful at quitting smoking than non-depressed smokers.[46] [184]

Relapse (resuming smoking after quitting) has been related to psychological issues such as low self-efficacy,[185] [186] or non-optimal coping responses;[187] however, psychological approaches to prevent relapse have not been proven to be successful.[188] In contrast, varenicline is suggested to have some effects and nicotine replacement therapy may help the unassisted abstainers.[189]

Side effects

Duration of nicotine withdrawal symptoms
Craving for tobacco3 to 8 weeks
DizzinessFew days
Insomnia1 to 2 weeks
Headaches1 to 2 weeks
Chest discomfort1 to 2 weeks
Constipation1 to 2 weeks
Irritability2 to 4 weeks
Fatigue2 to 4 weeks
Cough or nasal dripFew weeks
Lack of concentrationFew weeks
HungerUp to several weeks[190]

Withdrawal symptoms

The CDC recognizes seven common nicotine withdrawal symptoms that people often face when stopping smoking: "cravings to smoke, feeling irritated, grouchy, or upset, feeling jumpy and restless, having a hard time concentrating, having trouble sleeping, feeling hungry or gaining weight, or feeling anxious, sad or depressed."[191] Studies have shown that the use of pharmacotherapies, such as varenicline[192] [193] can be useful in reducing withdrawal symptoms during the quitting process.

Weight gain

Giving up smoking is associated with an average weight gain of 4kg-5kgkg (09lb-11lbkg) after 12 months, most of which occurs within the first three months of quitting.[194]

The possible causes of the weight gain include:

The U.S. Department of Health and Human Services guideline suggests that sustained-release bupropion, nicotine gum, and nicotine lozenge be used "to delay weight gain after quitting."[198] There is not currently enough evidence to suggest one method of weight loss works better than others in preventing weight gain during the smoking cessation process.[199] [200] It is helpful to reach for healthy snacks, such as celery and carrots, to aid in the increased appetite while also helping to limit weight gain. Regardless of post-cessation weight gain, there is a significant decrease in risk of cardiovascular disease in those who have quit smoking.[201] The risks of rebound weight gain is significantly less than the risks of continued smoking.

Mental health

Like other physically addictive drugs, nicotine addiction causes a down-regulation of the production of dopamine and other stimulatory neurotransmitters as the brain attempts to compensate for the artificial stimulation caused by smoking. Some studies from the 1990s found that when people stop smoking, depressive symptoms such as suicidal tendencies or actual depression may result,[184] [202] although a recent international study comparing smokers who had stopped for 3 months with continuing smokers found that stopping smoking did not appear to increase anxiety or depression.[203] A 2021 review found that quitting smoking lessens anxiety and depression.[204]

A 2013 study by The British Journal of Psychiatry has found that smokers who successfully quit feel less anxious afterward, with the effect being greater among those who had mood and anxiety disorders than those who smoked for pleasure.[205]

Health benefits

Many of tobacco's detrimental health effects can be reduced or largely removed through smoking cessation. The health benefits over time of stopping smoking include:[206]

The British Doctors Study showed that those who stopped smoking before they reached 30 years old lived almost as long as those who never smoked. Stopping in one's sixties can still add three years of healthy life. Randomized U.S. and Canadian trials showed that a ten-week smoking cessation program decreased mortality from all causes over 14 years later.[207] A recent article on mortality in a cohort of 8,645 smokers who were followed up after 43 years determined that "current smoking and lifetime persistent smoking were associated with an increased risk of all-cause, CVD [cardiovascular disease], COPD [chronic obstructive pulmonary disease], and any cancer, and lung cancer mortality."[208]

The significant increase in the risk of all-cause mortality that is present in people who smoke is decreased with long-term smoking cessation.[209] Smoking cessation can improve health status and quality of life at any age.[210] Evidence shows that cessation of smoking reduces risk of lung, laryngeal, oral cavity and pharynx, esophageal, pancreatic, bladder, stomach, colorectal, cervical, and kidney cancer, in addition to reducing the risk of acute myeloid leukemia.

Another published study, "Smoking Cessation Reduces Postoperative Complications: A Systematic Review and Meta-analysis," examined six randomized trials and 15 observational studies to examine preoperative smoking cessation's effects on postoperative complications. The findings were: 1) taken together, the studies demonstrated a decreased likelihood of postoperative complications in patients who ceased smoking before surgery; 2) overall, each week of cessation before surgery increased the magnitude of the effect by 19%. A significant positive effect was noted in trials where smoking cessation occurred at least four weeks before surgery; 3) For the six randomized trials, they demonstrated, on average, a relative risk reduction of 41% for postoperative complications.[211]

Cost-effectiveness

Cost-effectiveness analyses of smoking cessation activities have shown that they increase quality-adjusted life years (QALYs) at costs comparable with other types of interventions to treat and prevent disease.[46] Studies of the cost-effectiveness of smoking cessation include:

Statistical trends

The frequency of smoking cessation among smokers varies across countries. Smoking cessation increased in Spain between 1965 and 2000,[215] in Scotland between 1998 and 2007,[216] and in Italy after 2000.[217] In contrast, in the U.S. the cessation rate was "stable (or varied little)" between 1998 and 2008,[218] and in China smoking cessation rates declined between 1998 and 2003.[219]

Nevertheless, in a growing number of countries there are now more ex-smokers than smokers.[31] In the United States, 61.7% of adult smokers (55.0 million adults) who had ever smoked had quit by 2018, an increase from 51.7% in 2009.[220] As of 2020, the CDC reports that the number of adults who smoke in the U.S. has fallen to 30.8 million.[221]

See also

Further reading

Notes and References

  1. Web site: 2022 . Take steps NOW to stop smoking . www.nhs.uk . . . https://web.archive.org/web/20220529024422/https://www.nhs.uk/better-health/quit-smoking/ . 29 May 2022 . 31 May 2022 . live.
  2. Web site: 2022 . How to Quit Smoking or Smokeless Tobacco . live . www.cancer.org . . . https://web.archive.org/web/20220525083936/https://www.cancer.org/healthy/stay-away-from-tobacco/guide-quitting-smoking.html . 25 May 2022 . 31 May 2022.
  3. Kalkhoran S, Benowitz NL, Rigotti NA . Prevention and Treatment of Tobacco Use: JACC Health Promotion Series . Journal of the American College of Cardiology . 72 . 9 . 1030–1045 . August 2018 . 30139432 . 6261256 . 10.1016/j.jacc.2018.06.036 . . 52077567 . free .
  4. Rodu B, Plurphanswat N . Mortality among male cigar and cigarette smokers in the USA . Harm Reduction Journal . 18 . 1 . 7 . January 2021 . 33413424 . 7789747 . 10.1186/s12954-020-00446-4 . live . . 230800394 . 28 August 2021 . 2004243422 . https://web.archive.org/web/20210826115030/https://harmreductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-020-00446-4.pdf . 26 August 2021 . free .
  5. Nonnemaker J, Rostron B, Hall P, MacMonegle A, Apelberg B . Mortality and economic costs from regular cigar use in the United States, 2010 . American Journal of Public Health . 104 . 9 . e86–e91 . September 2014 . 25033140 . 4151956 . 10.2105/AJPH.2014.301991 . . 207276270 . Alfredo Morabia . 1541-0048 . Morabia A .
  6. Shah RS, Cole JW . Smoking and stroke: the more you smoke the more you stroke . Expert Review of Cardiovascular Therapy . 8 . 7 . 917–932 . July 2010 . 20602553 . 2928253 . 10.1586/erc.10.56 . . 207215548 .
  7. Laniado-Laborín R . Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century . International Journal of Environmental Research and Public Health . 6 . 1 . 209–224 . January 2009 . 19440278 . 2672326 . 10.3390/ijerph6010209 . . 19615031 . free .
  8. Oh CK, Murray LA, Molfino NA . Smoking and idiopathic pulmonary fibrosis . Pulmonary Medicine . 2012 . 808260 . February 2012 . 22448328 . 3289849 . 10.1155/2012/808260 . . 14090263 . free .
  9. Shapiro JA, Jacobs EJ, Thun MJ . Cigar smoking in men and risk of death from tobacco-related cancers . Journal of the National Cancer Institute . 92 . 4 . 333–337 . February 2000 . 10675383 . 10.1093/jnci/92.4.333 . live . . 1460-2105 . https://web.archive.org/web/20210421095250/https://academic.oup.com/jnci/article/92/4/333/2624751 . 7772405 . 28 August 2021 . 21 April 2021 . Patricia A. Ganz . free . Ganz PA N.
  10. Book: Anjum F, Zohaib J . Definitions . Oropharyngeal Squamous Cell Carcinoma . 4 December 2020 . https://www.ncbi.nlm.nih.gov/books/NBK563268/ . StatPearls . Treasure Island (FL) . StatPearls Publishing . Updated . Bookshelf ID: NBK563268 . 10.32388/G6TG1L . 33085415 . 229252540 . . 7 February 2021.
  11. Chandrupatla SG, Tavares M, Natto ZS . Tobacco Use and Effects of Professional Advice on Smoking Cessation among Youth in India . Asian Pacific Journal of Cancer Prevention . 18 . 7 . 1861–1867 . July 2017 . 28749122 . 5648391 . 10.22034/APJCP.2017.18.7.1861 .
  12. Temitayo Orisasami I, Ojo O . Evaluating the effectiveness of smoking cessation in the management of COPD . British Journal of Nursing . 25 . 14 . 786–791 . July 2016 . 27467642 . 10.12968/bjon.2016.25.14.786 .
  13. Web site: World Health Organization. . WHO Report on the global tobacco epidemic . 2015 . July 8, 2015. https://web.archive.org/web/20150708132528/http://www.who.int/tobacco/global_report/2015/en/.
  14. Web site: Tobacco . 2024-02-24 . www.who.int . en.
  15. Web site: . 31 March 2022 . Vaping and quitting smoking . live . www.canada.ca . . . https://web.archive.org/web/20220508060133/https://www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/smokers.html . 8 May 2022 . 31 May 2022.
  16. Web site: . 29 March 2022 . Using e-cigarettes to stop smoking . live . www.nhs.uk . . . https://web.archive.org/web/20220511143245/https://www.nhs.uk/live-well/quit-smoking/using-e-cigarettes-to-stop-smoking/ . 11 May 2022 . 31 May 2022.
  17. . 15 November 2019 . Long-term smokers who start vaping see health benefits within a month . live . Wilson E . Emily Wilson (journalist) . . . 0262-4079 . https://web.archive.org/web/20220305003531/https://www.newscientist.com/article/2223624-long-term-smokers-who-start-vaping-see-health-benefits-within-a-month/ . 5 March 2022 . 31 May 2022.
  18. Assessment of formal tobacco treatment and smoking cessation in dual users of cigarettes and e-cigarettes . 35863765 . 2022 . Heiden . B. T. . Baker . T. B. . Smock . N. . Pham . G. . Chen . J. . Bierut . L. J. . Chen . L. S. . Thorax . 78 . 3 . 267–273 . 10.1136/thorax-2022-218680 . 9852353.
  19. Rigotti NA . Strategies to help a smoker who is struggling to quit . JAMA . 308 . 15 . 1573–1580 . October 2012 . 23073954 . 4562427 . 10.1001/jama.2012.13043 .
  20. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T . Combined pharmacotherapy and behavioural interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2016 . CD008286 . March 2016 . 3 . 27009521 . 10.1002/14651858.CD008286.pub3 . 10042551 . 29033457 .
  21. Rosen LJ, Galili T, Kott J, Goodman M, Freedman LS . Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials . Addiction . 113 . 5 . 805–816 . May 2018 . 29377409 . 5947828 . 10.1111/add.14134 . . 4764039 .
  22. Benowitz NL . Nicotine addiction . The New England Journal of Medicine . 362 . 24 . 2295–2303 . June 2010 . 20554984 . 2928221 . 10.1056/NEJMra0809890 .
  23. Caraballo RS, Shafer PR, Patel D, Davis KC, McAfee TA . Quit Methods Used by US Adult Cigarette Smokers, 2014-2016 . Preventing Chronic Disease . 14 . E32 . April 2017 . 28409740 . 5392446 . 10.5888/pcd14.160600 .
  24. Chaiton M, Diemert L, Cohen JE, Bondy SJ, Selby P, Philipneri A, Schwartz R . Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers . BMJ Open . 6 . 6 . e011045 . June 2016 . 27288378 . 4908897 . 10.1136/bmjopen-2016-011045 .
  25. Hughes JR, Keely J, Naud S . January 2004 . Shape of the relapse curve and long-term abstinence among untreated smokers . Addiction . 99 . 1 . 29–38 . 10.1111/j.1360-0443.2004.00540.x . 14678060.
  26. Edwards SA, Bondy SJ, Callaghan RC, Mann RE . Prevalence of unassisted quit attempts in population-based studies: a systematic review of the literature . Addictive Behaviors . 39 . 3 . 512–519 . March 2014 . 24333037 . 10.1016/j.addbeh.2013.10.036 .
  27. Mooney ME, Johnson EO, Breslau N, Bierut LJ, Hatsukami DK . Cigarette smoking reduction and changes in nicotine dependence . Nicotine & Tobacco Research . 13 . 6 . 426–430 . June 2011 . 21367813 . 3103717 . 10.1093/ntr/ntr019 . . 00244999 . 29891495 . Marcus Munafo . Munafò M .
  28. Lee CW, Kahende J . Factors associated with successful smoking cessation in the United States, 2000 . American Journal of Public Health . 97 . 8 . 1503–1509 . August 2007 . 17600268 . 1931453 . 10.2105/AJPH.2005.083527.
  29. Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, Surawicz TS, Davis RM . 1990 . Methods used to quit smoking in the United States. Do cessation programs help? . JAMA . 263 . 20 . 2760–2765 . 10.1001/jama.1990.03440200064024 . 2271019.
  30. Doran CM, Valenti L, Robinson M, Britt H, Mattick RP . May 2006 . Smoking status of Australian general practice patients and their attempts to quit . Addictive Behaviors . 31 . 5 . 758–766 . 10.1016/j.addbeh.2005.05.054 . 16137834.
  31. Chapman S, MacKenzie R . The global research neglect of unassisted smoking cessation: causes and consequences . PLOS Medicine . 7 . 2 . e1000216 . February 2010 . 20161722 . 2817714 . 10.1371/journal.pmed.1000216 . free .
  32. Hung WT, Dunlop SM, Perez D, Cotter T . Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters . BMC Public Health . 11 . 592 . July 2011 . 21791111 . 3160379 . 10.1186/1471-2458-11-592 . free .
  33. Lindson N, Klemperer E, Hong B, Ordóñez-Mena JM, Aveyard P . September 2019 . Smoking reduction interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 9 . CD013183 . 10.1002/14651858.CD013183.pub2 . 6953262 . 31565800.
  34. Web site: Guide to quitting smoking. What do I need to know about quitting . American Cancer Society . 2014 . 2017-01-08 . 2016-06-09 . https://web.archive.org/web/20160609085602/http://www.cancer.org/acs/groups/cid/documents/webcontent/002971-pdf.pdf .
  35. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T . Nicotine replacement therapy versus control for smoking cessation . The Cochrane Database of Systematic Reviews . 5 . 5 . CD000146 . May 2018 . 29852054 . 6353172 . 10.1002/14651858.CD000146.pub5 .
  36. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T . Nicotine replacement therapy versus control for smoking cessation . The Cochrane Database of Systematic Reviews . 5 . CD000146 . May 2018 . 5 . 29852054 . 6353172 . 10.1002/14651858.CD000146.pub5 .
  37. Zhou HX . The debut of PMC Biophysics . PMC Biophysics . 1 . 1 . 1 . November 2008 . 19351423 . 2605105 . 10.1186/1757-5036-1-1 . free .
  38. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML . Pharmacotherapy for nicotine dependence . CA . 55 . 5 . 281–99; quiz 322–3, 325 . 2005 . 16166074 . 10.3322/canjclin.55.5.281 . 25668093 . free .
  39. News: Millstone K . Nixing the patch: Smokers quit cold turkey. 2007-02-13 . Columbia.edu News Service. 2011-02-21 . https://web.archive.org/web/20181225010214/http://jscms.jrn.columbia.edu/cns/2007-02-13/millstone-coldturkeyquitters.html . 2018-12-25.
  40. Lancaster T, Stead LF . Mecamylamine (a nicotine antagonist) for smoking cessation . The Cochrane Database of Systematic Reviews . 2 . CD001009 . 2000 . 1998 . 10796584 . 7271835 . 10.1002/14651858.CD001009 .
  41. Hajizadeh . Anisa . Howes . Seth . Theodoulou . Annika . Klemperer . Elias . Hartmann-Boyce . Jamie . Livingstone-Banks . Jonathan . Lindson . Nicola . 2023-05-24 . Antidepressants for smoking cessation . The Cochrane Database of Systematic Reviews . 2023 . 5 . CD000031 . 10.1002/14651858.CD000031.pub6 . 1469-493X . 10207863 . 37230961.
  42. Web site: Product monograph Champix . Pfizer Canada . April 17, 2015 . https://web.archive.org/web/20151116204234/http://www.pfizer.ca/sites/g/files/g10023216/f/201505/CHAMPIX_PM_E_181247_17Apr2015.pdf . 2015-11-16.
  43. Livingstone-Banks . Jonathan . Fanshawe . Thomas R. . Thomas . Kyla H. . Theodoulou . Annika . Hajizadeh . Anisa . Hartman . Lilian . Lindson . Nicola . 2023-05-05 . Nicotine receptor partial agonists for smoking cessation . The Cochrane Database of Systematic Reviews . 2023 . 5 . CD006103 . 10.1002/14651858.CD006103.pub8 . 1469-493X . 10169257 . 37142273.
  44. Sterling LH, Windle SB, Filion KB, Touma L, Eisenberg MJ . Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials . Journal of the American Heart Association . 5 . 2 . e002849 . February 2016 . 26903004 . 4802486 . 10.1161/JAHA.115.002849 .
  45. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE . Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial . Lancet . 387 . 10037 . 2507–2520 . June 2016 . 27116918 . 10.1016/s0140-6736(16)30272-0 . 1611308 .
  46. Book: Clinical practice guideline: treating tobacco use and dependence: 2008 update. Fiore MC, Jaén CR, Baker TB. U.S. Department of Health and Human Services, Public Health Service. 2008 . Rockville, MD. 2016-07-06. https://web.archive.org/web/20160327225607/http://bphc.hrsa.gov/buckets/treatingtobacco.pdf. 2016-03-27. unfit.
  47. Gourlay SG, Stead LF, Benowitz NL . Clonidine for smoking cessation . The Cochrane Database of Systematic Reviews . 2008 . 3 . CD000058 . 2004 . 15266422 . 7038651 . 10.1002/14651858.CD000058.pub2 .
  48. Hughes JR, Stead LF, Lancaster T . Anxiolytics for smoking cessation . The Cochrane Database of Systematic Reviews . 2011 . 4 . CD002849 . 2000 . 11034774 . 8407461 . 10.1002/14651858.CD002849 .
  49. Cahill K, Ussher MH . Cannabinoid type 1 receptor antagonists for smoking cessation . The Cochrane Database of Systematic Reviews . 3 . CD005353 . March 2011 . 2011 . 21412887 . 6486173 . 10.1002/14651858.CD005353.pub4 .
  50. Secker-Walker RH, Gnich W, Platt S, Lancaster T . Community interventions for reducing smoking among adults . The Cochrane Database of Systematic Reviews . 3 . CD001745 . 2002 . 2002 . 12137631 . 6464950 . 10.1002/14651858.CD001745 .
  51. Lemmens V, Oenema A, Knut IK, Brug J . Effectiveness of smoking cessation interventions among adults: a systematic review of reviews . European Journal of Cancer Prevention . 17 . 6 . 535–544 . November 2008 . 18941375 . 10.1097/CEJ.0b013e3282f75e48 . 46131720 . https://web.archive.org/web/20110706080753/http://www.cmtabaquismo.com.ar/documentos/Lemmens%20et%20al%20EJCP%202008%20Cochrane%20intervenciones.pdf . 2011-07-06 .
  52. Web site: Agency for Healthcare Research and Quality . State-Mandated Tobacco Ban, Integration of Cessation Services, and Other Policies Reduce Smoking Among Patients and Staff at Substance Abuse Treatment Centers . 2013-02-27 . 2013-05-13.
  53. ((Centers for Disease Control and Prevention (CDC))) . State-specific prevalence of smoke-free home rules--United States, 1992-2003 . MMWR. Morbidity and Mortality Weekly Report . 56 . 20 . 501–504 . May 2007 . 17522588 .
  54. King BA, Dube SR, Homa DM . Smoke-free rules and secondhand smoke exposure in homes and vehicles among US adults, 2009-2010 . Preventing Chronic Disease . 10 . E79 . May 2013 . 23680508 . 3666976 . 10.5888/pcd10.120218 .
  55. King BA, Babb SD, Tynan MA, Gerzoff RB . National and state estimates of secondhand smoke infiltration among U.S. multiunit housing residents . Nicotine & Tobacco Research . 15 . 7 . 1316–1321 . July 2013 . 23248030 . 4571449 . 10.1093/ntr/nts254 .
  56. Bala MM, Strzeszynski L, Topor-Madry R . Mass media interventions for smoking cessation in adults . The Cochrane Database of Systematic Reviews . 2017 . 11 . CD004704 . November 2017 . 29159862 . 6486126 . 10.1002/14651858.CD004704.pub4 .
  57. Frazer K, McHugh J, Callinan JE, Kelleher C . Impact of institutional smoking bans on reducing harms and secondhand smoke exposure . The Cochrane Database of Systematic Reviews . 5 . CD011856 . May 2016 . 2016 . 27230795 . 10.1002/14651858.CD011856.pub2 . 10164285 .
  58. Fai . Sui Chee . Yen . Gan Kim . Malik . Nurdiyana . 2016 . Quit rates at 6 months in a pharmacist-led smoking cessation service in Malaysia . Canadian Pharmacists Journal / Revue des Pharmaciens du Canada . en . 149 . 5 . 303–312 . 10.1177/1715163516662894 . 1715-1635 . 5032936 . 27708676.
  59. Erku . Daniel . Hailemeskel . Bisrat . Netere . Adeladlew . Belachew . Sewunet . 2019-01-09 . Pharmacist-led smoking cessation services in Ethiopia: Knowledge and skills gap analysis . Tobacco Induced Diseases . 17 . January . 01 . 10.18332/tid/99573 . 1617-9625 . 6751994 . 31582913.
  60. Brown . Tamara J . Todd . Adam . O'Malley . Claire . Moore . Helen J . Husband . Andrew K . Bambra . Clare . Kasim . Adetayo . Sniehotta . Falko F . Steed . Liz . Smith . Sarah . Nield . Lucie . Summerbell . Carolyn D . 2016 . Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation . BMJ Open . en . 6 . 2 . e009828 . 10.1136/bmjopen-2015-009828 . free . 2044-6055 . 4780058 . 26928025 .
  61. Web site: Hendrick B . Computer is an ally in quit-smoking fight . WebMD.
  62. Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM . Effects of Web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials . Archives of Internal Medicine . 169 . 10 . 929–937 . May 2009 . 19468084 . 10.1001/archinternmed.2009.109 . free.
  63. Taylor GM, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J . Internet-based interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2017 . 9 . CD007078 . September 2017 . 10.1002/14651858.CD007078.pub5 . 28869775 . 6703145 .
  64. Hutton HE, Wilson LM, Apelberg BJ, Tang EA, Odelola O, Bass EB, Chander G . A systematic review of randomized controlled trials: Web-based interventions for smoking cessation among adolescents, college students, and adults . Nicotine & Tobacco Research . 13 . 4 . 227–238 . April 2011 . 21350042 . 10.1093/ntr/ntq252 . free.
  65. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y . Mobile phone-based interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 4 . CD006611 . April 2016 . 4 . 27060875 . 6485940 . 10.1002/14651858.CD006611.pub4.
  66. 2020-02-12 . Text messaging support helps smokers quit, but apps not yet shown to work . NIHR Evidence . Plain English summary . National Institute for Health and Care Research . 10.3310/signal-000876. 241974258 .
  67. What is digital health technology and what can it do for me? . NIHR Evidence . 2022 . 10.3310/nihrevidence_53447 . 252584020.
  68. Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, Rodgers A, Cairns J, Kenward MG, Roberts I . Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial . Lancet . 378 . 9785 . 49–55 . July 2011 . 21722952 . 3143315 . 10.1016/s0140-6736(11)60701-0.
  69. Free C, Phillips G, Watson L, Galli L, Felix L, Edwards P, Patel V, Haines A . The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis . PLOS Medicine . 10 . 1 . e1001363 . 2013 . 23458994 . 3566926 . 10.1371/journal.pmed.1001363 . free .
  70. Brendryen H, Kraft P . Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention . Addiction . 103 . 3 . 478–484; discussion 485–486 . March 2008 . 18269367 . 10.1111/j.1360-0443.2007.02119.x. 4638860 .
  71. Brendryen H, Drozd F, Kraft P . A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): randomized controlled trial . Journal of Medical Internet Research . 10 . 5 . e51 . November 2008 . 19087949 . 2630841 . 10.2196/jmir.1005 . free .
  72. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M, Gutiérrez-Terrell E . Evidence of real-world effectiveness of a telephone quitline for smokers . The New England Journal of Medicine . 347 . 14 . 1087–1093 . October 2002 . 12362011 . 10.1056/NEJMsa020660 . free .
  73. Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H . Factors related to abstinence in a telephone helpline for smoking cessation . European Journal of Public Health . 14 . 3 . 306–310 . September 2004 . 15369039 . 10.1093/eurpub/14.3.306 . free .
  74. Lancaster T, Stead LF . Individual behavioural counselling for smoking cessation . The Cochrane Database of Systematic Reviews . 2018 . 3 . CD001292 . March 2017 . 28361496 . 6464359 . 10.1002/14651858.CD001292.pub3 .
  75. Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J . Telephone counselling for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 5 . CD002850 . May 2019 . 31045250 . 6496404 . 10.1002/14651858.CD002850.pub4 . Cochrane Tobacco Addiction Group .
  76. Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR . Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 6 . CD009670 . June 2019 . 31166007 . 6549450 . 10.1002/14651858.CD009670.pub4 .
  77. Baskerville NB, Azagba S, Norman C, McKeown K, Brown KS . Effect of a Digital Social Media Campaign on Young Adult Smoking Cessation . Nicotine & Tobacco Research . 18 . 3 . 351–360 . March 2016 . 26045252 . 10.1093/ntr/ntv119 .
  78. Stead LF, Carroll AJ, Lancaster T . Group behaviour therapy programmes for smoking cessation . The Cochrane Database of Systematic Reviews . 2017 . 3 . CD001007 . March 2017 . 28361497 . 6464070 . 10.1002/14651858.CD001007.pub3 .
  79. Lindson-Hawley N, Thompson TP, Begh R . Motivational interviewing for smoking cessation . The Cochrane Database of Systematic Reviews . 3 . CD006936 . March 2015 . 25726920 . 10.1002/14651858.CD006936.pub3 .
  80. Hettema JE, Hendricks PS . Motivational interviewing for smoking cessation: a meta-analytic review . Journal of Consulting and Clinical Psychology . 78 . 6 . 868–884 . December 2010 . 21114344 . 10.1037/a0021498 .
  81. Heckman CJ, Egleston BL, Hofmann MT . Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis . Tobacco Control . 19 . 5 . 410–416 . October 2010 . 20675688 . 2947553 . 10.1136/tc.2009.033175 .
  82. Book: Perkins KA, Conklin CA, Levine MD . Cognitive-behavioral therapy for smoking cessation: a practical guidebook to the most effective treatment . 2008 . Routledge . New York . 978-0-415-95463-1.
  83. Ruiz FJ . 2010 . A review of Acceptance and Commitment Therapy (ACT) empirical evidence: Correlational, experimental psychopathology, component and outcome studies . International Journal of Psychology and Psychological Therapy . 10 . 1 . 125–162 .
  84. Web site: About Freedom From Smoking. American Lung Association.
  85. Prochaska JO, Velicer WF, DiClemente CC, Fava J . Measuring processes of change: applications to the cessation of smoking . Journal of Consulting and Clinical Psychology . 56 . 4 . 520–528 . August 1988 . 3198809 . 10.1037/0022-006X.56.4.520 .
  86. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS . The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change . Journal of Consulting and Clinical Psychology . 59 . 2 . 295–304 . April 1991 . 2030191 . 10.1037/0022-006X.59.2.295 . unfit . https://web.archive.org/web/20110606230703/http://www.uri.edu/research/cprc/Publications/PDFs/ByTitle/The%20Process%20of%20smoking%20cessation%20an%20analysis%20of%20precomtemplation.pdf . 2011-06-06 .
  87. Velicer WF, Prochaska JO, Rossi JS, Snow MG . Assessing outcome in smoking cessation studies . Psychological Bulletin . 111 . 1 . 23–41 . January 1992 . 1539088 . 10.1037/0033-2909.111.1.23 .
  88. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS . Standardized, individualized, interactive, and personalized self-help programs for smoking cessation . Health Psychology . 12 . 5 . 399–405 . September 1993 . 8223364 . 10.1037/0278-6133.12.5.399 . unfit . https://web.archive.org/web/20110606231216/http://www.uri.edu/research/cprc/Publications/PDFs/ByTitle/Standardized%20individualized%20interactive%20and%20Personalized.pdf . 2011-06-06 .
  89. Cahill K, Lancaster T, Green N . Stage-based interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 11 . CD004492 . November 2010 . 21069681 . 10.1002/14651858.CD004492.pub4 . Cahill K .
  90. Web site: Making a Quit Plan . 19 October 2015 . Centers for Disease Control and Prevention.
  91. Web site: Preparing for Quit Day . 19 October 2015 . Mayo Clinic .
  92. Smit ES, Hoving C, Schelleman-Offermans K, West R, de Vries H . September 2014 . Predictors of successful and unsuccessful quit attempts among smokers motivated to quit . Addictive Behaviors . 39 . 9 . 1318–1324 . 10.1016/j.addbeh.2014.04.017 . 24837754.
  93. de Vries H, Eggers SM, Bolman C . April 2013 . The role of action planning and plan enactment for smoking cessation . BMC Public Health . 13 . 393 . 10.1186/1471-2458-13-393 . 3644281 . 23622256 . free .
  94. Bolman C, Eggers SM, van Osch L, Te Poel F, Candel M, de Vries H . Oct 2015 . Is Action Planning Helpful for Smoking Cessation? Assessing the Effects of Action Planning in a Web-Based Computer-Tailored Intervention . Substance Use & Misuse . 50 . 10 . 1249–1260 . 10.3109/10826084.2014.977397 . 26440754 . 20337590.
  95. Ayers JW, Althouse BM, Johnson M, Cohen JE . January 2014 . Circaseptan (weekly) rhythms in smoking cessation considerations . JAMA Internal Medicine . 174 . 1 . 146–148 . 10.1001/jamainternmed.2013.11933 . 4670616 . 24166181.
  96. Erbas B, Bui Q, Huggins R, Harper T, White V . February 2006 . Investigating the relation between placement of Quit antismoking advertisements and number of telephone calls to Quitline: a semiparametric modelling approach . Journal of Epidemiology and Community Health . 60 . 2 . 180–182 . 10.1136/jech.2005.038109 . 2566152 . 16415271.
  97. Web site: Dr Anil Om Murthi Archives . 2024-02-05 . Enewspolar . en.
  98. Livingstone-Banks J, Ordóñez-Mena JM, Hartmann-Boyce J . Print-based self-help interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 1 . CD001118 . January 2019 . 1 . 30623970 . 7112723 . 10.1002/14651858.CD001118.pub4 .
  99. Web site: Nicotine Anonymous offers help for those who desire to live free from nicotine . nicotine-anonymous.org.
  100. Glasser I . Nicotine anonymous may benefit nicotine-dependent individuals . American Journal of Public Health . 100 . 2 . 196; author reply 196-196; author reply 197 . February 2010 . 20019295 . 2804638 . 10.2105/ajph.2009.181545 .
  101. Web site: U.S. Department of Health and Human Services. MySmokeFree: Your personalized quit experience . Smokefree.gov.
  102. Web site: Slideshow: 13 Best Quit-Smoking Tips Ever. WebMD.
  103. Book: Carr A . The easy way to stop smoking . 2004 . Sterling . New York . 978-1-4027-7163-7.
  104. Gonzales D, Redtomahawk D, Pizacani B, Bjornson WG, Spradley J, Allen E, Lees P . Support for spirituality in smoking cessation: results of pilot survey . Nicotine & Tobacco Research . 9 . 2 . 299–303 . February 2007 . 17365761 . 10.1080/14622200601078582 .
  105. Tang YY, Tang R, Posner MI . Mindfulness meditation improves emotion regulation and reduces drug abuse . Drug and Alcohol Dependence . 163 . Suppl 1 . S13–S18 . June 2016 . 27306725 . 10.1016/j.drugalcdep.2015.11.041 . free .
  106. Ussher MH, Faulkner GE, Angus K, Hartmann-Boyce J, Taylor AH . Exercise interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 10 . October 2019 . 31684691 . 6819982 . 10.1002/14651858.CD002295.pub6 .
  107. Bittoun R . 2008 . Carbon monoxide meter: The essential clinical tool- the 'stethoscope"-of smoking cessation . Journal of Smoking Cessation . 3 . 2 . 69–70 . 10.1375/jsc.3.2.69. free .
  108. Jamrozik K, Vessey M, Fowler G, Wald N, Parker G, Van Vunakis H . Controlled trial of three different antismoking interventions in general practice . British Medical Journal . 288 . 6429 . 1499–1503 . May 1984 . 6426618 . 1441184 . 10.1136/bmj.288.6429.1499 .
  109. Clair C, Mueller Y, Livingstone-Banks J, Burnand B, Camain JY, Cornuz J, Rège-Walther M, Selby K, Bize R . Biomedical risk assessment as an aid for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 3 . CD004705 . March 2019 . 30912847 . 6434771 . 10.1002/14651858.CD004705.pub5 .
  110. Irving JM, Clark EC, Crombie IK, Smith WC . Evaluation of a portable measure of expired-air carbon monoxide . Preventive Medicine . 17 . 1 . 109–115 . January 1988 . 3362796 . 10.1016/0091-7435(88)90076-x .
  111. Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G . Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology . Therapeutic Drug Monitoring . 31 . 1 . 14–30 . February 2009 . 19125149 . 3644554 . 10.1097/FTD.0b013e3181957a3b .
  112. McClure JB . Are biomarkers a useful aid in smoking cessation? A review and analysis of the literature . Behavioral Medicine . 27 . 1 . 37–47 . 2001 . 11575171 . 10.1080/08964280109595770 . 25616883 .
  113. Notley C, Gentry S, Livingstone-Banks J, Bauld L, Perera R, Hartmann-Boyce J . Incentives for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 7 . CD004307 . July 2019 . 31313293 . 6635501 . 10.1002/14651858.CD004307.pub6 .
  114. Dylan S. Small . Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, Loewenstein G, Brennan TA, Asch DA, Volpp KG . Randomized trial of four financial-incentive programs for smoking cessation . The New England Journal of Medicine . 372 . 22 . 2108–2117 . May 2015 . 25970009 . 4471993 . 10.1056/NEJMoa1414293 .
  115. Fanshawe TR, Hartmann-Boyce J, Perera R, Lindson N . Competitions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 2 . CD013272 . February 2019 . 30784046 . 6953205 . 10.1002/14651858.CD013272 .
  116. Cahill K, Lancaster T . February 2014 . Workplace interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2 . CD003440 . 10.1002/14651858.CD003440.pub4 . 24570145. 11285308 .
  117. Leeks KD, Hopkins DP, Soler RE, Aten A, Chattopadhyay SK . February 2010 . Worksite-based incentives and competitions to reduce tobacco use. A systematic review . American Journal of Preventive Medicine . 38 . Suppl 2 . S263–S274 . 10.1016/j.amepre.2009.10.034 . 20117611.
  118. Hopkins DP, Briss PA, Ricard CJ, Husten CG, Carande-Kulis VG, Fielding JE, Alao MO, McKenna JW, Sharp DJ, Harris JR, Woollery TA, Harris KW . Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke . American Journal of Preventive Medicine . 20 . 2 Suppl . 16–66 . February 2001 . 11173215 . 10.1016/S0749-3797(00)00297-X .
  119. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T . Physician advice for smoking cessation . The Cochrane Database of Systematic Reviews . 5 . CD000165 . May 2013 . 2013 . 23728631 . 7064045 . 10.1002/14651858.CD000165.pub4 .
  120. Maguire CP, Ryan J, Kelly A, O'Neill D, Coakley D, Walsh JB . Do patient age and medical condition influence medical advice to stop smoking? . Age and Ageing . 29 . 3 . 264–266 . May 2000 . 10855911 . 10.1093/ageing/29.3.264 . free .
  121. Ossip-Klein DJ, McIntosh S, Utman C, Burton K, Spada J, Guido J . Smokers ages 50+: who gets physician advice to quit? . Preventive Medicine . 31 . 4 . 364–369 . October 2000 . 11006061 . 10.1006/pmed.2000.0721 .
  122. Rice VH, Heath L, Livingstone-Banks J, Hartmann-Boyce J . Nursing interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2017 . 12 . CD001188 . December 2017 . 29243221 . 6486227 . 10.1002/14651858.CD001188.pub5 .
  123. Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R, Bond CM . Community pharmacy personnel interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 10 . October 2019 . 31684695 . 6822095 . 10.1002/14651858.CD003698.pub3 .
  124. Holliday . Richard . Hong . Bosun . McColl . Elaine . Livingstone-Banks . Jonathan . Preshaw . Philip M. . 2021-02-19 . Interventions for tobacco cessation delivered by dental professionals . The Cochrane Database of Systematic Reviews . 2021 . 2 . CD005084 . 10.1002/14651858.CD005084.pub4 . 1469-493X . 8095016 . 33605440.
  125. Carson KV, Verbiest ME, Crone MR, Brinn MP, Esterman AJ, Assendelft WJ, Smith BJ . Training health professionals in smoking cessation . The Cochrane Database of Systematic Reviews . 5 . 5 . CD000214 . May 2012 . 22592671 . 10.1002/14651858.CD000214.pub2 . 10088066 . free . Carson KV . 2066/110023 .
  126. van den Brand FA, Nagelhout GE, Reda AA, Winkens B, Evers SM, Kotz D, van Schayck OC . Healthcare financing systems for increasing the use of tobacco dependence treatment . The Cochrane Database of Systematic Reviews . 2017 . 9 . CD004305 . September 2017 . 28898403 . 6483741 . 10.1002/14651858.CD004305.pub5 .
  127. Papadakis S, McDonald P, Mullen KA, Reid R, Skulsky K, Pipe A . Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis . Preventive Medicine . 51 . 3–4 . 199–213 . 2010 . 20600264 . 10.1016/j.ypmed.2010.06.007 .
  128. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T . Nicotine replacement therapy versus control for smoking cessation . The Cochrane Database of Systematic Reviews . 5 . CD000146 . May 2018 . 5 . 29852054 . 6353172 . 10.1002/14651858.CD000146.pub5 . Cochrane Tobacco Addiction Group .
  129. Hartmann-Boyce . J . Lindson . N . Butler . AR . McRobbie . H . Bullen . C . Begh . R . Theodoulou . A . Notley . C . Rigotti . NA . Turner . T . Fanshawe . TR . Hajek . P . Electronic cigarettes for smoking cessation. . The Cochrane Database of Systematic Reviews . 17 November 2022 . 2022 . 11 . CD010216 . 10.1002/14651858.CD010216.pub7 . 36384212. 9668543 .
  130. Formanek P, Salisbury-Afshar E, Afshar M . Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking . American Journal of Kidney Diseases . 72 . 2 . 255–266 . August 2018 . 29661542 . 6057817 . 10.1053/j.ajkd.2018.01.057 .
  131. Web site: Royal College of Physicians. RCP statement on e-cigarettes . RCP London. 25 June 2014.
  132. Web site: McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H . E-cigarettes: an evidence update. UK. Public Health England . 6 . August 2015.
  133. He D, Berg JE, Høstmark AT . Effects of acupuncture on smoking cessation or reduction for motivated smokers . Preventive Medicine . 26 . 2 . 208–214 . March 1997 . 9085389 . 10.1006/pmed.1996.0125 .
  134. White AR, Rampes H, Liu JP, Stead LF, Campbell J . Acupuncture and related interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 1 . 1 . CD000009 . January 2014 . 24459016 . 7263424 . 10.1002/14651858.CD000009.pub4 .
  135. Web site: Hypnosis for Quitting Smoking. WebMD. 19 May 2012.
  136. Johnson DL, Karkut RT . Performance by gender in a stop-smoking program combining hypnosis and aversion . Psychological Reports . 75 . 2 . 851–857 . October 1994 . 7862796 . 10.2466/pr0.1994.75.2.851 . 39850409 .
  137. Law M, Tang JL . An analysis of the effectiveness of interventions intended to help people stop smoking . Archives of Internal Medicine . 155 . 18 . 1933–1941 . October 1995 . 7575046 . 10.1001/archinte.1995.00430180025004 .
  138. Barnes J, McRobbie H, Dong CY, Walker N, Hartmann-Boyce J . Hypnotherapy for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 6 . CD001008 . June 2019 . 31198991 . 6568235 . 10.1002/14651858.CD001008.pub3 .
  139. Carmody TP, Duncan C, Simon JA, Solkowitz S, Huggins J, Lee S, Delucchi K . Hypnosis for smoking cessation: a randomized trial . Nicotine & Tobacco Research . 10 . 5 . 811–818 . May 2008 . 18569754 . 10.1080/14622200802023833 . 36395279 .
  140. Web site: Mayo Clinic. St. John's wort (Hypericum perforatum) Evidence . Mayo Clinic.
  141. Sood A, Ebbert JO, Prasad K, Croghan IT, Bauer B, Schroeder DR . A randomized clinical trial of St. John's wort for smoking cessation . Journal of Alternative and Complementary Medicine . 16 . 7 . 761–767 . July 2010 . 20590478 . 3110810 . 10.1089/acm.2009.0445 .
  142. Web site: U.S. Food and Drug Administration. FDA Poisonous Plant Database. www.accessdata.fda.gov. 2019-11-11. 2022-01-21. https://web.archive.org/web/20220121131935/https://www.accessdata.fda.gov/scripts/Plantox/.
  143. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) . Health Effects of Smokeless Tobacco Products . 103 .
  144. Web site: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Health effects of smokeless tobacco products.
  145. Popova L, Ling PM . Alternative tobacco product use and smoking cessation: a national study . American Journal of Public Health . 103 . 5 . 923–930 . May 2013 . 23488521 . 3661190 . 10.2105/ajph.2012.301070 .
  146. Hajek P, Stead LF . Aversive smoking for smoking cessation . The Cochrane Database of Systematic Reviews . 3 . CD000546 . 2004 . 2001 . 15266433 . 7045729 . 10.1002/14651858.CD000546.pub2 .
  147. Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J . Nicotine vaccines for smoking cessation . The Cochrane Database of Systematic Reviews . 8 . CD007072 . August 2012 . 2012 . 22895958 . 6486305 . 10.1002/14651858.CD007072.pub2 .
  148. Coughlin LN, Tegge AN, Sheffer CE, Bickel WK . A Machine-Learning Approach to Predicting Smoking Cessation Treatment Outcomes . Nicotine & Tobacco Research . 22 . 3 . 415–422 . March 2020 . 30508122 . 7297111 . 10.1093/ntr/nty259 .
  149. Sadasivam RS, Borglund EM, Adams R, Marlin BM, Houston TK . Impact of a Collective Intelligence Tailored Messaging System on Smoking Cessation: The Perspect Randomized Experiment . Journal of Medical Internet Research . 18 . 11 . e285 . November 2016 . 27826134 . 5120237 . 10.2196/jmir.6465 . free .
  150. Patrick H, Fujii CA, Glaser DB, Utley DS, Marler JD . A Comprehensive Digital Program for Smoking Cessation: Assessing Feasibility in a Single-Group Cohort Study . JMIR mHealth and uHealth . 6 . 12 . e11708 . December 2018 . 30563807 . 6315234 . 10.2196/11708 . free .
  151. Web site: Marisol M . 2021-10-20. Johns Hopkins receives first federal grant for psychedelic treatment research in 50 years. The Hub. en . 2022-01-29.
  152. Fanshawe TR, Halliwell W, Lindson N, Aveyard P, Livingstone-Banks J, Hartmann-Boyce J . Tobacco cessation interventions for young people . The Cochrane Database of Systematic Reviews . 2017 . 11 . CD003289 . November 2017 . 29148565 . 6486118 . 10.1002/14651858.CD003289.pub6 .
  153. Web site: Phert L . Intensive Counseling of Students by School Nurses Does Not Have Larger Impact on Long-Term Smoking Rates Than Briefer Sessions AHRQ Health Care Innovations Exchange . innovations.ahrq.gov . 19 July 2016.
  154. Davis KC, Farrelly MC, Messeri P, Duke J . The impact of national smoking prevention campaigns on tobacco-related beliefs, intentions to smoke and smoking initiation: results from a longitudinal survey of youth in the United States . International Journal of Environmental Research and Public Health . 6 . 2 . 722–740 . February 2009 . 19440412 . 2672353 . 10.3390/ijerph6020722 . free .
  155. Allen JA, Duke JC, Davis KC, Kim AE, Nonnemaker JM, Farrelly MC . Using mass media campaigns to reduce youth tobacco use: a review . American Journal of Health Promotion . 30 . 2 . e71–e82 . Nov–Dec 2015 . 25372236 . 10.4278/ajhp.130510-lit-237 . 9297116 .
  156. Carson KV, Brinn MP, Labiszewski NA, Esterman AJ, Chang AB, Smith BJ . Community interventions for preventing smoking in young people . The Cochrane Database of Systematic Reviews . 7 . CD001291 . July 2011 . 21735383 . 10.1002/14651858.CD001291.pub2 .
  157. Mund M, Louwen F, Klingelhoefer D, Gerber A . Smoking and pregnancy--a review on the first major environmental risk factor of the unborn . International Journal of Environmental Research and Public Health . 10 . 12 . 6485–6499 . November 2013 . 24351784 . 3881126 . 10.3390/ijerph10126485 . free .
  158. Anderson TM, Lavista Ferres JM, Ren SY, Moon RY, Goldstein RD, Ramirez JM, Mitchell EA . Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death . Pediatrics . 143 . 4 . e20183325 . April 2019 . 30858347 . 6564075 . 10.1542/peds.2018-3325 .
  159. Chamberlain C, O'Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, McKenzie JE . Psychosocial interventions for supporting women to stop smoking in pregnancy . The Cochrane Database of Systematic Reviews . 2 . 3 . CD001055 . February 2017 . 28196405 . 4022453 . 10.1002/14651858.CD001055.pub5 .
  160. Web site: Bowen M . Pregnancy and smoking. Netdoctor. 19 July 2016. 25 February 2013.
  161. 2022-11-04 . E-cigarettes may be better than nicotine patches in helping pregnant women stop smoking . NIHR Evidence . en . 10.3310/nihrevidence_54425. 253360129 .
  162. Hajek P, Przulj D, Pesola F, Griffiths C, Walton R, McRobbie H, Coleman T, Lewis S, Whitemore R, Clark M, Ussher M, Sinclair L, Seager E, Cooper S, Bauld L, Naughton F, Sasieni P, Manyonda I, Myers Smith K . Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial . Nature Medicine . 28 . 5 . 958–964 . May 2022 . 35577966 . 9117131 . 10.1038/s41591-022-01808-0 .
  163. de Leon J, Diaz FJ . A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors . Schizophrenia Research . 76 . 2–3 . 135–157 . July 2005 . 15949648 . 10.1016/j.schres.2005.02.010 . 32975940 .
  164. Keltner NL, Grant JS . Smoke, smoke, smoke that cigarette . Perspectives in Psychiatric Care . 42 . 4 . 256–261 . November 2006 . 17107571 . 10.1111/j.1744-6163.2006.00085.x .
  165. Rigotti NA, Clair C, Munafò MR, Stead LF . Interventions for smoking cessation in hospitalised patients . The Cochrane Database of Systematic Reviews . 5 . CD001837 . May 2012 . 5 . 22592676 . 4498489 . 10.1002/14651858.CD001837.pub3 .
  166. Thomsen T, Villebro N, Møller AM . Interventions for preoperative smoking cessation . The Cochrane Database of Systematic Reviews . 3 . CD002294 . March 2014 . 2014 . 24671929 . 7138216 . 10.1002/14651858.CD002294.pub4 .
  167. Moylan S, Jacka FN, Pasco JA, Berk M . How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways . Brain and Behavior . 3 . 3 . 302–326 . May 2013 . 23785661 . 3683289 . 10.1002/brb3.137 .
  168. Baggett TP, Lebrun-Harris LA, Rigotti NA . Homelessness, cigarette smoking and desire to quit: results from a US national study . Addiction . 108 . 11 . 2009–2018 . November 2013 . 23834157 . 3797258 . 10.1111/add.12292 .
  169. Web site: Other Vulnerable Populations . Smoking Cessation Leadership Center. 8 September 2015. 2017-06-29.
  170. Web site: National Coalition for the Homeless. www.nationalhomeless.org. 2017-06-29.
  171. Web site: CDC – Fact Sheet – Adult Cigarette Smoking in the United States – Smoking & Tobacco Use . CDC's Office on Smoking and Health . Smoking and Tobacco Use. en-us. 2017-06-29.
  172. Baggett TP, Tobey ML, Rigotti NA . Tobacco use among homeless people--addressing the neglected addiction . The New England Journal of Medicine . 369 . 3 . 201–204 . July 2013 . 23863048 . 10.1056/NEJMp1301935 . free .
  173. Iyahen . Eric Osayemwenre . Omoruyi . Osazee Omoregbe . Rowa-Dewar . Neneh . Dobbie . Fiona . 2023-07-13 . Exploring the barriers and facilitators to the uptake of smoking cessation services for people in treatment or recovery from problematic drug or alcohol use: A qualitative systematic review . PLOS ONE . en . 18 . 7 . e0288409 . 10.1371/journal.pone.0288409 . free . 1932-6203 . 10343091 . 37440505. 2023PLoSO..1888409I .
  174. Campbell BK, Le T, Andrews KB, Pramod S, Guydish J . Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks . The American Journal of Drug and Alcohol Abuse . 42 . 6 . 649–656 . November 2016 . 27314450 . 5093078 . 10.1080/00952990.2016.1183021 .
  175. Hartmann-Boyce . Jamie . 4 January 2021 . Behavioural interventions for smoking cessation: an overview and network meta-analysis . Cochrane Database of Systematic Reviews . 1 . 1. Art. No.: CD013229. CD013229 . 10.1002/14651858.CD013229.pub2 . 33411338 . 230814023 .
  176. Apollonio D, Philipps R, Bero L . Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders . The Cochrane Database of Systematic Reviews . 11 . CD010274 . November 2016 . 11 . 27878808 . 6464324 . 10.1002/14651858.CD010274.pub2 .
  177. Prochaska . Judith J. . Delucchi . Kevin . Hall . Sharon M. . December 2004 . A Meta-Analysis of Smoking Cessation Interventions With Individuals in Substance Abuse Treatment or Recovery. . Journal of Consulting and Clinical Psychology . en . 72 . 6 . 1144–1156 . 10.1037/0022-006X.72.6.1144 . 15612860 . 1939-2117.
  178. Lemmens V, Oenema A, Knut IK, Brug J . Effectiveness of smoking cessation interventions among adults: a systematic review of reviews . European Journal of Cancer Prevention . 17 . 6 . 535–544 . November 2008 . 18941375 . 10.1097/cej.0b013e3282f75e48 . 46131720 .
  179. King G, Yerger VB, Whembolua GL, Bendel RB, Kittles R, Moolchan ET . Link between facultative melanin and tobacco use among African Americans . Pharmacology, Biochemistry, and Behavior . 92 . 4 . 589–596 . June 2009 . 19268687 . 10.1016/j.pbb.2009.02.011 . 2012-09-12 . unfit . 3070838 . https://web.archive.org/web/20160304071838/http://chicago.medicine.uic.edu/UserFiles/Servers/Server_442934/File/IHG/Kittleslab/documents/Melanin%20and%20Nicotine%20Article%20-%20Publication.pdf . 2016-03-04 .
  180. Christakis NA, Fowler JH . The collective dynamics of smoking in a large social network . The New England Journal of Medicine . 358 . 21 . 2249–2258 . May 2008 . 18499567 . 2822344 . 10.1056/NEJMsa0706154 .
  181. Faseru B, Richter KP, Scheuermann TS, Park EW . Enhancing partner support to improve smoking cessation . The Cochrane Database of Systematic Reviews . 8 . 9 . CD002928 . August 2018 . 30101972 . 6326744 . 10.1002/14651858.CD002928.pub4 .
  182. Hitchman SC, Fong GT, Zanna MP, Thrasher JF, Laux FL . The relation between number of smoking friends, and quit intentions, attempts, and success: findings from the International Tobacco Control (ITC) Four Country Survey . Psychology of Addictive Behaviors . 28 . 4 . 1144–1152 . December 2014 . 24841185 . 4266625 . 10.1037/a0036483 .
  183. Web site: American Cancer Society. Guide to Quitting Smoking. www.cancer.org. 6 July 2016. 8 August 2016. https://web.archive.org/web/20160808163637/http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/.
  184. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J . Smoking, smoking cessation, and major depression . JAMA . 264 . 12 . 1546–1549 . September 1990 . 2395194 . 10.1001/jama.1990.03450120058029 .
  185. Condiotte MM, Lichtenstein E . Self-efficacy and relapse in smoking cessation programs . Journal of Consulting and Clinical Psychology . 49 . 5 . 648–658 . October 1981 . 7287974 . 10.1037/0022-006X.49.5.648 .
  186. Elfeddali I, Bolman C, Candel MJ, Wiers RW, De Vries H . The role of self-efficacy, recovery self-efficacy, and preparatory planning in predicting short-term smoking relapse . British Journal of Health Psychology . 17 . 1 . 185–201 . February 2012 . 22107073 . 10.1111/j.2044-8287.2011.02032.x . 32854923 .
  187. Shiffman S . Relapse following smoking cessation: a situational analysis . Journal of Consulting and Clinical Psychology . 50 . 1 . 71–86 . February 1982 . 7056922 . 10.1037/0022-006X.50.1.71 .
  188. Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Chubb E, Hajek P . Relapse prevention interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 10 . October 2019 . 31684681 . 6816175 . 10.1002/14651858.CD003999.pub6 .
  189. Agboola SA, Coleman T, McNeill A, Leonardi-Bee J . Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials . Addiction . 110 . 7 . 1182–1193 . July 2015 . 25846123 . 10.1111/add.12941 .
  190. Book: Kaiser Foundation Health Plan of the Northwest. Cultivating Health: Freedom From Tobacco Kit. 2008. Kaiser Permanente. 978-0-9744864-8-2.
  191. Web site: 2022-09-12 . 7 Common Withdrawal Symptoms Quit Smoking Tips From Former Smokers CDC . 2022-12-06 . www.cdc.gov . en-us.
  192. Lopes . Luciane Cruz . Zhang . Yuan . Ross . Stephanie . Fulone . Izabela . Zhu . Meng . O'Brien . Kelly K. . Pavalagantharajah . Sureka . Leone . Frank T. . Sachs . David P. L. . Kathuria . Hasmeena . Murray . Rachael L. . Zhang . Yu-Qing . December 2022 . Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis . Annals of the American Thoracic Society . 19 . 12 . 2077–2086 . 10.1513/AnnalsATS.202110-1122OC . 2325-6621 . 36129426. 252406073 .
  193. Zaso . Michelle J. . Hendershot . Christian S. . September 2022 . Effects of varenicline and bupropion on laboratory smoking outcomes: Meta-analysis of randomized, placebo-controlled human laboratory studies . Addiction Biology . 27 . 5 . e13218 . 10.1111/adb.13218 . 1369-1600 . 9413474 . 36001439.
  194. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P . Weight gain in smokers after quitting cigarettes: meta-analysis . BMJ . 345 . 345 . e4439 . July 2012 . 22782848 . 3393785 . 10.1136/bmj.e4439 .
  195. Vanni H, Kazeros A, Wang R, Harvey BG, Ferris B, De BP, Carolan BJ, Hübner RH, O'Connor TP, Crystal RG . Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human . Chest . 135 . 5 . 1197–1208 . May 2009 . 19188554 . 2679098 . 10.1378/chest.08-1024 .
  196. Jo YH, Talmage DA, Role LW . Nicotinic receptor-mediated effects on appetite and food intake . Journal of Neurobiology . 53 . 4 . 618–632 . December 2002 . 12436425 . 2367209 . 10.1002/neu.10147 .
  197. Book: Johns Hopkins family health book . Klag MJ . 1999. 86. HarperCollins . New York . 978-0-06-270149-7.
  198. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.
  199. Hartmann-Boyce . Jamie . Theodoulou . Annika . Farley . Amanda . Hajek . Peter . Lycett . Deborah . Jones . Laura L. . Kudlek . Laura . Heath . Laura . Hajizadeh . Anisa . Schenkels . Marika . Aveyard . Paul . 2021-10-06 . Interventions for preventing weight gain after smoking cessation . The Cochrane Database of Systematic Reviews . 2021 . 10 . CD006219 . 10.1002/14651858.CD006219.pub4 . 1469-493X . 8493442 . 34611902.
  200. Ussher . Michael H. . Faulkner . Guy E. J. . Angus . Kathryn . Hartmann-Boyce . Jamie . Taylor . Adrian H. . 2019-10-30 . Exercise interventions for smoking cessation . The Cochrane Database of Systematic Reviews . 2019 . 10 . CD002295 . 10.1002/14651858.CD002295.pub6 . 1469-493X . 6819982 . 31684691.
  201. Wang . Xiaowen . Qin . Li-Qiang . Arafa . Ahmed . Eshak . Ehab S. . Hu . Yonghua . Dong . Jia-Yi . 2021-11-05 . Smoking Cessation, Weight Gain, Cardiovascular Risk, and All-Cause Mortality: A Meta-analysis . Nicotine & Tobacco Research. 23 . 12 . 1987–1994 . 10.1093/ntr/ntab076 . 1469-994X . 33876246. free .
  202. Covey LS, Glassman AH, Stetner F . Major depression following smoking cessation . The American Journal of Psychiatry . 154 . 2 . 263–265 . February 1997 . 10.1176/ajp.154.2.263 . 9016279 .
  203. Shahab L, Andrew S, West R . Changes in prevalence of depression and anxiety following smoking cessation: results from an international cohort study (ATTEMPT) . Psychological Medicine . 44 . 1 . 127–141 . January 2014 . 23507203 . 10.1017/s0033291713000391 . 36478156 .
  204. Taylor . Gemma Mj . Lindson . Nicola . Farley . Amanda . Leinberger-Jabari . Andrea . Sawyer . Katherine . Te Water Naudé . Rebecca . Theodoulou . Annika . King . Naomi . Burke . Chloe . Aveyard . Paul . 2021-03-09 . Smoking cessation for improving mental health . The Cochrane Database of Systematic Reviews . 2021 . 3 . CD013522 . 10.1002/14651858.CD013522.pub2 . 1469-493X . 8121093 . 33687070.
  205. McDermott MS, Marteau TM, Hollands GJ, Hankins M, Aveyard P . Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study . The British Journal of Psychiatry . 202 . 1 . 62–67 . January 2013 . 23284151 . 10.1192/bjp.bp.112.114389 . free .
  206. Web site: Health Benefits of Quitting Smoking Over Time . 2022-12-06 . www.cancer.org . en.
  207. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE . The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial . Annals of Internal Medicine . 142 . 4 . 233–239 . February 2005 . 15710956 . 10.7326/0003-4819-142-4-200502150-00005 . 20252771 .
  208. Taghizadeh N, Vonk JM, Boezen HM . Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up . PLOS ONE . 11 . 4 . e0153310 . 7 April 2016 . 27055053 . 4824471 . 10.1371/journal.pone.0153310 . free . 2016PLoSO..1153310T .
  209. Zhu . Di . Zhao . Gang . Wang . Xia . April 2021 . Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality . American Journal of Preventive Medicine . 60 . 4 . 504–512 . 10.1016/j.amepre.2020.11.003 . 1873-2607 . 33745522. 232311701 . free .
  210. Smoking cessation: A report of the surgeon general—executive summary. US Public Health Service; US Department of Health and Human Services, Rockville, MD 2020.
  211. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO . Smoking cessation reduces postoperative complications: a systematic review and meta-analysis . The American Journal of Medicine . 124 . 2 . 144–154.e8 . February 2011 . 21295194 . 10.1016/j.amjmed.2010.09.013.
  212. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T . Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research . JAMA . 278 . 21 . 1759–1766 . December 1997 . 9388153 . 10.1001/jama.278.21.1759 .
  213. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP . Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD . Thorax . 65 . 8 . 711–718 . August 2010 . 20685746 . 10.1136/thx.2009.131631 . free .
  214. Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, Hiscock R . One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services . Nicotine & Tobacco Research . 13 . 2 . 135–145 . February 2011 . 21196451 . 10.1093/ntr/ntq222 .
  215. Schiaffino A, Fernández E, Kunst A, Borrell C, García M, Borràs JM, Mackenbach JP . Time trends and educational differences in the incidence of quitting smoking in Spain (1965-2000) . Preventive Medicine . 45 . 2–3 . 226–232 . 2007 . 17604832 . 10.1016/j.ypmed.2007.05.009 .
  216. Fowkes FJ, Stewart MC, Fowkes FG, Amos A, Price JF . Scottish smoke-free legislation and trends in smoking cessation . Addiction . 103 . 11 . 1888–1895 . November 2008 . 19032538 . 10.1111/j.1360-0443.2008.02350.x .
  217. Federico B, Costa G, Ricciardi W, Kunst AE . Educational inequalities in smoking cessation trends in Italy, 1982-2002 . Tobacco Control . 18 . 5 . 393–398 . October 2009 . 19617220 . 10.1136/tc.2008.029280 . 9911187 .
  218. Cigarette smoking among adults and trends in smoking cessation - United States, 2008 . MMWR. Morbidity and Mortality Weekly Report . 58 . 44 . 1227–1232 . November 2009 . 19910909 . Centers for Disease Control Prevention (CDC) .
  219. Qian J, Cai M, Gao J, Tang S, Xu L, Critchley JA . Trends in smoking and quitting in China from 1993 to 2003: National Health Service Survey data . Bulletin of the World Health Organization . 88 . 10 . 769–776 . October 2010 . 20931062 . 2947036 . 10.2471/BLT.09.064709 .
  220. Creamer . MeLisa R. . 2019 . Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018 . MMWR. Morbidity and Mortality Weekly Report . en-us . 68 . 45 . 1013–1019 . 10.15585/mmwr.mm6845a2 . 31725711 . 6855510 . 0149-2195.
  221. Web site: CDCTobaccoFree . 2022-08-08 . Burden of Tobacco Use in the U.S. . 2022-12-06 . Centers for Disease Control and Prevention . en-us.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Smoking cessation".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.